ID29437A - Kombinasi dari formoterol dan flutikason propionat untuk asma - Google Patents

Kombinasi dari formoterol dan flutikason propionat untuk asma

Info

Publication number
ID29437A
ID29437A IDW00200101675A ID20011675A ID29437A ID 29437 A ID29437 A ID 29437A ID W00200101675 A IDW00200101675 A ID W00200101675A ID 20011675 A ID20011675 A ID 20011675A ID 29437 A ID29437 A ID 29437A
Authority
ID
Indonesia
Prior art keywords
flutikason
asma
formoterol
propionate
combinations
Prior art date
Application number
IDW00200101675A
Other languages
English (en)
Inventor
J G Clarke
H L Danahay
I F Hassan
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10848051&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ID29437(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of ID29437A publication Critical patent/ID29437A/id

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/166—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the carbon of a carboxamide group directly attached to the aromatic ring, e.g. procainamide, procarbazine, metoclopramide, labetalol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0078—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a nebulizer such as a jet nebulizer, ultrasonic nebulizer, e.g. in the form of aqueous drug solutions or dispersions

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Otolaryngology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IDW00200101675A 1999-02-18 2000-02-16 Kombinasi dari formoterol dan flutikason propionat untuk asma ID29437A (id)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9903759.0A GB9903759D0 (en) 1999-02-18 1999-02-18 Organic compounds

Publications (1)

Publication Number Publication Date
ID29437A true ID29437A (id) 2001-08-30

Family

ID=10848051

Family Applications (1)

Application Number Title Priority Date Filing Date
IDW00200101675A ID29437A (id) 1999-02-18 2000-02-16 Kombinasi dari formoterol dan flutikason propionat untuk asma

Country Status (31)

Country Link
US (4) US20020103260A1 (id)
EP (1) EP1152753B1 (id)
JP (1) JP2002537249A (id)
KR (2) KR20070104955A (id)
CN (1) CN1339965A (id)
AR (1) AR022609A1 (id)
AT (1) ATE266393T1 (id)
AU (1) AU758999B2 (id)
BR (1) BR0008276A (id)
CA (1) CA2368537A1 (id)
CO (1) CO5140098A1 (id)
CZ (1) CZ20012976A3 (id)
DE (1) DE60010662T2 (id)
DK (1) DK1152753T3 (id)
ES (1) ES2220411T3 (id)
GB (1) GB9903759D0 (id)
HU (1) HUP0200852A3 (id)
ID (1) ID29437A (id)
IL (1) IL144061A (id)
MY (1) MY126768A (id)
NO (1) NO20013987L (id)
NZ (1) NZ513526A (id)
PE (1) PE20001545A1 (id)
PL (1) PL349856A1 (id)
PT (1) PT1152753E (id)
RU (1) RU2249454C2 (id)
SK (1) SK11842001A3 (id)
TR (1) TR200102110T2 (id)
TW (1) TWI229601B (id)
WO (1) WO2000048587A1 (id)
ZA (1) ZA200105391B (id)

Families Citing this family (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9616237D0 (en) 1996-08-01 1996-09-11 Norton Healthcare Ltd Aerosol formulations
GB2392164B (en) * 1999-09-11 2004-04-07 Glaxo Group Ltd Pharmaceutical formulation of fluticasone propionate
GB2388843B (en) * 1999-09-11 2004-03-03 Glaxo Group Ltd A metered dose inhaler containing a pharmaceutical formulation of fluticasone propionate
CA2317999C (en) 1999-09-11 2004-11-09 Glaxo Group Limited Pharmaceutical formulation of fluticasone propionate
PL358375A1 (en) * 2000-04-13 2004-08-09 Innovata Biomed Limited Medicaments for treating respiratory disorders comprising formoterol and fluticasone
GB0009591D0 (en) * 2000-04-18 2000-06-07 Glaxo Group Ltd Medical combinations
GB0012260D0 (en) 2000-05-19 2000-07-12 Astrazeneca Ab Novel composition
US6759398B2 (en) * 2000-08-05 2004-07-06 Smithkline Beecham Corporation Anti-inflammatory androstane derivative
FI20002215A0 (fi) 2000-10-06 2000-10-06 Orion Yhtymae Oyj Yhdistelmäpartikkelit
FI20002216A0 (fi) 2000-10-06 2000-10-06 Orion Yhtymae Oyj Yhdistelmäpartikkelit astman hoitoon
WO2002062317A2 (en) * 2001-02-06 2002-08-15 Innovata Biomed Limited Bimodal dry powder formulation for inhalation
GB0106031D0 (en) * 2001-03-12 2001-05-02 Glaxo Group Ltd Use
ATE375142T1 (de) * 2001-03-30 2007-10-15 Jagotec Ag Medizinische aerosolformulierungen
US20030055026A1 (en) * 2001-04-17 2003-03-20 Dey L.P. Formoterol/steroid bronchodilating compositions and methods of use thereof
US6667344B2 (en) 2001-04-17 2003-12-23 Dey, L.P. Bronchodilating compositions and methods
US7931022B2 (en) 2001-10-19 2011-04-26 Respirks, Inc. Method and apparatus for dispensing inhalator medicament
ATE396716T1 (de) † 2002-02-04 2008-06-15 Glaxo Group Ltd Zubereitung zur inhalation enthaltend ein glucocorticoid und einen beta 2-adrenorezeptor agonisten
EP1757281A3 (en) * 2002-02-04 2009-07-15 Glaxo Group Limited Formulation for inhalation comprising a glucocorticoid and a beta 2-adrenoreceptor agonist
GB2389530B (en) 2002-06-14 2007-01-10 Cipla Ltd Pharmaceutical compositions
US20050158248A1 (en) * 2002-08-21 2005-07-21 Xian-Ming Zeng Method of preparing dry powder inhalation compositions
GB0219511D0 (en) * 2002-08-21 2002-10-02 Norton Healthcare Ltd Method of preparing dry powder inhalation compositions
ATE520405T1 (de) * 2002-08-21 2011-09-15 Norton Healthcare Ltd Inhalationszusammensetzung
JP4744876B2 (ja) * 2002-08-21 2011-08-10 ノートン・ヘルスケアー リミテッド 乾燥粉末吸入組成物の製造方法
WO2004028545A1 (en) * 2002-09-25 2004-04-08 Astrazeneca Ab A COMBINATION OF A LONG-ACTING β2-AGONIST AND A GLUCOCORTICOSTEROID IN THE TREATMENT OF FIBROTIC DISEASES
SE526850C2 (sv) * 2003-06-19 2005-11-08 Microdrug Ag Farmaceutisk kombinerad torr pulverdos separerade på gemensam dosbädd
SE527189C2 (sv) * 2003-06-19 2006-01-17 Microdrug Ag Inhalatoranordning samt kombinerade doser för formaterol och ett antikolinergiskt medel
SE527069C2 (sv) 2003-06-19 2005-12-13 Mederio Ag Förfarande och anordning för administrering av läkemedelspulver
SE526509C2 (sv) * 2003-06-19 2005-09-27 Microdrug Ag Kombinerade doser av formoterol och budesonid separerade på en gemensam dosbädd
SE527200C2 (sv) * 2003-06-19 2006-01-17 Microdrug Ag Inhalatoranordning samt kombinerade doser av formaterol och fluticason
TWI359675B (en) 2003-07-10 2012-03-11 Dey L P Bronchodilating β-agonist compositions
GB0323684D0 (en) * 2003-10-09 2003-11-12 Jagotec Ag Improvements in or relating to organic compounds
GB0323685D0 (en) * 2003-10-09 2003-11-12 Jagotec Ag Improvements in or relating to organic compounds
RU2431501C2 (ru) * 2005-07-14 2011-10-20 Липотера, Инк. Липолитические составы с пролонгированным высвобождением для локального лечения отложения жировых тканей
GB0617171D0 (en) * 2006-08-31 2006-10-11 Generics Uk Ltd Novel compositions and methods
WO2008137446A1 (en) * 2007-05-03 2008-11-13 Trustees Of Boston University Methods and compositions for the treatment of respiratory disease
US8815258B2 (en) 2009-05-29 2014-08-26 Pearl Therapeutics, Inc. Compositions, methods and systems for respiratory delivery of two or more active agents
AU2010253770B9 (en) * 2009-05-29 2015-02-12 Pearl Therapeutics, Inc. Compositions for respiratory delivery of active agents and associated methods and systems
GB0918150D0 (en) * 2009-10-16 2009-12-02 Jagotec Ag Improved formulations
GB0918149D0 (en) 2009-10-16 2009-12-02 Jagotec Ag Improved medicinal aerosol formulation
WO2011093811A2 (en) * 2010-01-29 2011-08-04 Mahmut Bilgic Pharmaceutical preparations comprising formoterol and fluticasone
MX2013004137A (es) * 2010-10-12 2013-07-29 Cipla Ltd Composicion farmaceutica.
KR20140032404A (ko) * 2011-05-17 2014-03-14 펄 테라퓨틱스 인코포레이티드 ２ 개 이상의 활성제의 호흡기 전달을 위한 조성물, 방법 ＆ 시스템
CA2869355A1 (en) * 2012-04-11 2013-10-17 Cipla Limited Pharmaceutical composition
US20140275517A1 (en) 2013-03-15 2014-09-18 Pearl Therapeutics, Inc. Methods and systems for conditioning of particulate crystalline materials

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL95590A (en) * 1989-09-08 1996-06-18 Glaxo Group Ltd Medicinal preparations containing Salmetrol and Pluticasone Propionate
SE9302777D0 (sv) * 1993-08-27 1993-08-27 Astra Ab Process for conditioning substances
US5658549A (en) * 1991-12-12 1997-08-19 Glaxo Group Limited Aerosol formulations containing propellant 134a and fluticasone propionate
SG48301A1 (en) * 1991-12-18 1998-04-17 Astra Ab New combination
GB9426252D0 (en) * 1994-12-24 1995-02-22 Glaxo Group Ltd Pharmaceutical composition
SE9700135D0 (sv) * 1997-01-20 1997-01-20 Astra Ab New formulation
DK1014943T3 (da) * 1997-02-05 2002-10-14 Jago Res Ag Medicinske aerosolformuleringer
DE69828155T2 (de) * 1997-03-20 2005-12-22 Schering Corp. Herstellung von pulveragglomeraten

Also Published As

Publication number Publication date
EP1152753B1 (en) 2004-05-12
HUP0200852A2 (en) 2002-08-28
NO20013987D0 (no) 2001-08-16
KR20010102205A (ko) 2001-11-15
US20040101487A1 (en) 2004-05-27
BR0008276A (pt) 2001-11-06
KR20070104955A (ko) 2007-10-29
US20050287079A1 (en) 2005-12-29
DE60010662T2 (de) 2005-05-19
PE20001545A1 (es) 2001-01-29
GB9903759D0 (en) 1999-04-14
NZ513526A (en) 2004-01-30
AU758999B2 (en) 2003-04-03
PL349856A1 (en) 2002-09-23
CA2368537A1 (en) 2000-08-24
ZA200105391B (en) 2002-06-21
US20020103260A1 (en) 2002-08-01
DK1152753T3 (da) 2004-08-16
JP2002537249A (ja) 2002-11-05
US20100034890A1 (en) 2010-02-11
MY126768A (en) 2006-10-31
CZ20012976A3 (cs) 2001-11-14
CO5140098A1 (es) 2002-03-22
IL144061A0 (en) 2002-04-21
SK11842001A3 (sk) 2001-12-03
AU2911500A (en) 2000-09-04
HUP0200852A3 (en) 2004-04-28
TR200102110T2 (tr) 2001-10-22
TWI229601B (en) 2005-03-21
PT1152753E (pt) 2004-09-30
ATE266393T1 (de) 2004-05-15
WO2000048587A1 (en) 2000-08-24
NO20013987L (no) 2001-08-16
IL144061A (en) 2005-12-18
AR022609A1 (es) 2002-09-04
ES2220411T3 (es) 2004-12-16
DE60010662D1 (de) 2004-06-17
HK1042429A1 (en) 2002-08-16
EP1152753A1 (en) 2001-11-14
RU2249454C2 (ru) 2005-04-10
CN1339965A (zh) 2002-03-13

Similar Documents

Publication Publication Date Title
PT1152753E (pt) Combinacoes de formoterol e propionato de fluticasona para asma
ID27922A (id) KOMPOSISI FARMASETIKAL DAN PENGGUNAAN DARI ANDROST-5-ENA-3β, 17β-DIOL
EE04297B1 (et) Budesoniidi ja formoterooli uus kasutamine
ID29994A (id) Komposisi farmasi untuk melawan ccr5 terdiri dari turunan anilida
ID29457A (id) Turunan dan analog asam 3-aril propionat
DE69912224D1 (de) Kombinierte Endkappe und Halterung
PT1238161E (pt) Fabrico de papel e papelao
ID24962A (id) Turunan-turunan sulfonamida sebagai bakal obat dari
ID29061A (id) METODE DAN KOMPOSISI UNTUK MEMPERBAIKI STABILITAS KONFORMASI SUATU PROTEIN DARI KELUARGA p53
NO990146D0 (no) Fluid omfattende cellulose nanofibriller og dets anvendelse for drift av oljefelt
ID27480A (id) Pembungkusan berstruktur dan elemennya
DE50015396D1 (de) Dynamische dichtung
GB0005199D0 (en) Modulation of histone deacetylase
FR2834043B1 (fr) Ensemble de serrage perfectionne et coupleur hydraulique le comportant
PT1228273E (pt) Fabrico de papel e papelao
PT1242685E (pt) Fabrico de papel e papelao
ID26137A (id) Komposisi farmasi baru dari uridin trifosfat
ID22091A (id) Metoda dan aparatus untuk penyaringan bubur dari kertas bekas
ID27996A (id) Polimorf dari suatu bahan farmasi
EP1162876A4 (en) REPLIABLE / DISMANTLING STRUCTURES
DE60107990D1 (de) Foliebehandlungsvorrichtung und Umwickelvorrichtung
NO20011491D0 (no) Reduksjon av oksidative stress faktorer
NO20030899D0 (no) Anvendelse av salmeterol og fluticasonpropionat kombinasjon
DE69913452D1 (de) Drehmomentwandler und dessen Dichtungsanordnung
DE69925120D1 (de) Molekulares stäbchen und dessen anwendungen